GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Soleno Therapeutics Inc (FRA:6XC) » Definitions » Interest Paid

Soleno Therapeutics (FRA:6XC) Interest Paid


View and export this data going back to 2019. Start your Free Trial

What is Soleno Therapeutics Interest Paid?

Interest Paid only applicable to companies reporting Cash Flow from Operations in direct method.


Soleno Therapeutics Business Description

Traded in Other Exchanges
Address
100 Marine Parkway, Suite 400, Redwood City, CA, USA, 94065
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.